Events


( Last Updated : February 23, 2006)

Pharmaceutical companies and other stakeholders are invited to comment on a revised procedure for CADTH’s drug reimbursement review processes (that is, the pan-Canadian Oncology Drug Review, the Common Drug Review, the Interim Plasma Protein Product Review, and the Interim Process for Cell and Gene…
Patient groups and other stakeholders are invited to comment on a revised procedure for CADTH’s drug reimbursement review processes (that is, the pan-Canadian Oncology Drug Review, the Common Drug Review, and the Interim Plasma Protein Product Review).  To help patient groups and patients…
According to the World Health Organization, the world is fighting the COVID-19 pandemic on two fronts — the disease itself and a related “infodemic” that it says is just as dangerous as the virus. An infodemic is an overwhelming flood of information, misinformation, rumours, and outright scams that…
In a few short weeks, the world as we knew it changed. The COVID-19 pandemic and the new reality that comes with it is the source of psychological trauma for many people. With limited access to face-to-face treatments, can technology play a role in addressing psychological trauma? This webinar will…
The magnitude of the COVID-19 pandemic globally is generating considerable interest in options to prevent infection and minimize the impact if infection occurs. Pre-exposure prophylaxis and post-exposure treatment with a group of drugs called antivirals, sometimes in combination with an antibiotic…